Latest News about ESALY
Recent news which mentions ESALY
Merck/Eisai's Keytruda-Lenvima Combo Tops Standard Of Care In Late-Stage Kidney Cancer Study
February 16, 2021
From Benzinga
Is the FDA Delay Actually Good News for Biogen's Alzheimer's Drug?
February 12, 2021
From Motley Fool
Biogen Shares Jump After FDA Delays Aducanumab Decision By 3 Months
January 29, 2021
From Benzinga
The Daily Biotech Pulse: Five Prime Skyrockets, Multiple Conference Presentations On Tap
November 11, 2020
From Benzinga
Analysts Predict Volatility In Biogen Shares Until March 2021
November 09, 2020
From Benzinga
From Benzinga
The Daily Biotech Pulse: Novavax Vaccine Data, Axovant Flags Delay In Parkinson's Study, 2 Biotechs Make Wall Street Debuts
October 30, 2020
From Benzinga
The Daily Biotech Pulse: Coronavirus Vaccine Updates From J&J & MediciNova, Australian Regulatory Nod For GW Pharma
September 23, 2020
From Benzinga
Biogen Soars As FDA Accepts Alzheimer's Drug For Review In 'Next Stage Of Aducanumab Saga'
August 07, 2020
From Benzinga
Earnings Scheduled For August 3, 2020
August 03, 2020
From Benzinga
The Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer Earnings
July 26, 2020
From Benzinga
From Benzinga
From Benzinga
The Daily Biotech Pulse: Intersect ENT Jumps On M&A Speculation, VIVUS Files For Bankruptcy
July 08, 2020
From Benzinga
The Daily Biotech Pulse: ASCO Presentations Begin, Altimmune Pops On Insider Buying, Immutep Gets R&D Grant
May 29, 2020
From Benzinga
Biogen Reports First-Quarter Results, Shares Plunge 9.4%
April 22, 2020
From Motley Fool
The Daily Biotech Pulse: InflaRx Begins Human Testing For COVID-induced Pneumonia, Chembio, Becton Dickinson Launch Coronavirus Tests
April 01, 2020
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
March 24, 2020
From Benzinga
The Daily Biotech Pulse: Epizyme's Tazemetostat sNDA Accepted For Priority Review, Eisai To Withdraw Weight Loss Drug, Sol-Gel Prices Offering
February 14, 2020
From Benzinga
Is Biogen Too Cheap to Ignore?
December 13, 2019
From Motley Fool
Biogen's Alzheimer's Drug 'Falls Far Short Of Compelling Argument For Approval,' Baird Says In Downgrade
December 02, 2019
From Benzinga
The Daily Biotech Pulse: FDA Nod For Sanofi, BioCryst's Edema Drug In Japan, Myriad's Q1 Disappointment
November 05, 2019
From Benzinga
Biogen’s stock blasts off after surprise reversal on Alzheimer’s drug, earnings beat
October 22, 2019
From MarketWatch
Biogen Plans Filing For Failed Alzheimer's Drug After New Analysis
October 22, 2019
From Benzinga
The Daily Biotech Pulse: Safety Scare For Anaptys' Psoriasis Drug, NewLink Genetics To Merge With Lumos, Insider Buy Props Up VBI Vaccines
October 01, 2019
From Benzinga
The Week Ahead In Biotech: Spotlight On ESMO Conference
September 22, 2019
From Benzinga
New 52-Week Lows For Monday Morning
August 05, 2019
From Benzinga
Stocks That Set New 52-Week Lows Friday Morning
August 02, 2019
From Benzinga
New 52-Week Lows for Tuesday Morning
July 30, 2019
From Benzinga
How to Invest in Cancer-Fighting Stocks
July 23, 2019
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.